Work

MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors

Year: 2015

Type: article

Source: Cell Death and Differentiation

DOI: 10.1038/cdd.2015.74

Authors: K L B Knorr, P A Schneider, X W Meng, H Dai, B D Smith, A D Hess, J E Karp, S H Kaufmann

Institutions: Mayo Clinic, Johns Hopkins University

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Mayo Clinic, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences

Awards: G1165598027, G1357033417, G2268222605, G267304645, Phase I Clinical Trials of New Anti-Cancer Targeted Therapies, G2809363847, Cytotoxicity of MLN4924 in Acute Myeloid Leukemia, G6312026533, G883206123, G9000015799, G9000126810, G9000180826, Mayo Clinic Comprehensive Cancer Center Support Grant, Medical Scientist Training Program at Mayo Clinic

OpenAlex ID: W1574166501

FWCI: 2.572

Cites: 61

Cited by: 97

Related to: 10